Log in
Enquire now
‌

US Patent 9974829 Methods and uses of slit for treating fibrosis

Patent 9974829 was granted and assigned to The Hospital for Sick Children on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
The Hospital for Sick Children
The Hospital for Sick Children
0
Current Assignee
The Hospital for Sick Children
The Hospital for Sick Children
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
99748290
Patent Inventor Names
Lisa Annette Robinson0
Darren Arthur Vee-Yip Yuen0
Date of Patent
May 22, 2018
0
Patent Application Number
156253990
Date Filed
June 16, 2017
0
Patent Primary Examiner
‌
Marcela M Cordero Garcia
0
Patent abstract

The present disclosure provides methods and uses of Slit protein and nucleic acid for inhibiting fibrosis and fibrotic-related disorders, for example, of the kidney, lung, heart, liver, or a wound. The Slit protein can be, for example, Slit2 or Slit2-N, or a Slit variant that can bind the Robo receptor and induce signalling. Also provided are pharmaceutical compositions comprising the Slit protein or nucleic acid and an additional anti-fibrotic agent.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9974829 Methods and uses of slit for treating fibrosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.